A Statewide Program to Stimulate Reporting of Adverse Drug Reactions

Abstract

The purpose of a 26-month Food and Drug Administration sponsored study conducted in Mississippi was to determine how the reporting of adverse drug reactions (ADRs) might be stimulated. The program included both institutional and community based health care facilities located in urban as well as rural settings. Methods used in the study increased the monthly average of reported ADRs from 3.94 to 16.5. Pharmacists have the expertise and responsibility to assume a more active role in the reporting of ADRs.